synthroid
viatris limited - levothyroxine sodium 50ug (plus a 3% manufacturing overage); levothyroxine sodium 50ug (plus a 9% manufacturing overage) - tablet - 50 mcg - active: levothyroxine sodium 50ug (plus a 3% manufacturing overage) excipient: acacia lactose monohydrate magnesium stearate povidone purified talc sucrose active: levothyroxine sodium 50ug (plus a 9% manufacturing overage) excipient: acacia lactose monohydrate magnesium stearate povidone purified talc sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.
synthroid
viatris limited - levothyroxine sodium 75ug (plus a 3% manufacturing overage); levothyroxine sodium 75ug (plus a 9% manufacturing overage) - tablet - 75 mcg - active: levothyroxine sodium 75ug (plus a 3% manufacturing overage) excipient: acacia allura red ac indigo carmine lactose monohydrate magnesium stearate povidone purified talc sucrose active: levothyroxine sodium 75ug (plus a 9% manufacturing overage) excipient: acacia allura red ac indigo carmine lactose monohydrate magnesium stearate povidone purified talc sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.
synthroid
viatris limited - levothyroxine sodium 88ug (plus a 3% manufacturing overage); levothyroxine sodium 88ug (plus a 9% manufacturing overage) - tablet - 88 mcg - active: levothyroxine sodium 88ug (plus a 3% manufacturing overage) excipient: acacia d&c olive lake blend lactose monohydrate magnesium stearate povidone purified talc quinoline yellow sucrose active: levothyroxine sodium 88ug (plus a 9% manufacturing overage) excipient: acacia d&c olive lake blend lactose monohydrate magnesium stearate povidone purified talc quinoline yellow sucrose - synthroid (levothyroxine sodium, usp) is indicated as replacement or supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism during the recovery phase of subacute thyroiditis; specific indication include: primary hypothyroidism resulting from thyroid dysfunction, primary atrophy, or partial or total absence of thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goiter, including subclinical hypothyroidism; secondary (pituitary) hypothyroidism; and tertiary (hypothalamic) hypothyroidism.
tyvaso
rafa laboratories ltd - treprostinil as sodium salt - solution for inhalation - treprostinil as sodium salt 1.74 mg / 2.9 ml - treprostinil - treprostinil - treatment of pulmonary arterial hypertension in patients with nyha class iii symptoms, to increase walk distance.pulmonary hypertension associated with interstitial lung disease (ph-ild; who group 3) to improve exercise ability.
nebido
bayer israel ltd - testosterone undecanoate - solution for injection - testosterone undecanoate 250 mg/ml - testosterone - testosterone - testosterone replacement therpay in primary and secondary male hypogonadism.
clindamycin injections
rafa laboratories ltd - clindamycin as phosphate - solution for injection - clindamycin as phosphate 150 mg/ml - clindamycin - clindamycin - the treatment of infections caused by susceptible anaerobic bacteria.
reyataz 200 mg
bristol - myers squibb, israel - atazanavir as sulfate - capsules - atazanavir as sulfate 200 mg - atazanavir - atazanavir - reyataz is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
prezista 400 mg
j-c health care ltd - darunavir as ethanolate - film coated tablets - darunavir as ethanolate 400 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.
prezista 600 mg
j-c health care ltd - darunavir as ethanolate - film coated tablets - darunavir as ethanolate 600 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.
oxycontin 20
rafa laboratories ltd - oxycodone hydrochloride - tablets controlled release - oxycodone hydrochloride 20 mg - oxycodone - oxycodone - for the relief of moderate severe chronic pain.